Skip to main content
. 2017 Dec 4;8(67):111697–111714. doi: 10.18632/oncotarget.22902

Table 2. Percentage of viable, apoptotic and necrotic HL-60 cells treated with 6-MITC for 24h, 48h and 72h.

HL-60 24h 48h 72h
viable cells apoptotic cells necrotic cells viable cells apoptotic cells necrotic cells viable cells apoptotic cells necrotic cells
0μM 93.7±02 5.3±0.1 1.1±0.1 94.3±0.5 4.7±0.3 1.0±0.4 94.6±0.2 3.8±0.2 1.3±0.1
2μM 93.9±0.1 5.2±0.1 0.9±0.1 93.9±0.1 4.9±0.1 1.3±0.1 95.9±0.1 3.1±0.1 1.0±0.2
4μM 91.9±0.4 7.1±0.3 1.0±0.2 91.6±0.6 6.8±0.4 1.6±0.2 92.1±8.9 6.3±0.5 1.4±0.2
8μM 83.0±0.4 12.7±0.2 3.3±0.2 66.5±1.5 22.6±1.0 10.5±0.8 58.5±1.7 31.5±2.0 10.0±0.4
16μM 46.8±0.9 12.6±0.5 39.2±0.8
32μM 33.3±0.5 15.8±0.4 51.1±0.6

Data are presented as mean ± SEM of five independent experiments.